Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where David R. Cooper is active.

Publication


Featured researches published by David R. Cooper.


Protein Science | 2007

Toward rational protein crystallization : A Web server for the design of crystallizable protein variants

Lukasz Goldschmidt; David R. Cooper; Zygmunt S. Derewenda; David Eisenberg

Growing well‐diffracting crystals constitutes a serious bottleneck in structural biology. A recently proposed crystallization methodology for “stubborn crystallizers” is to engineer surface sequence variants designed to form intermolecular contacts that could support a crystal lattice. This approach relies on the concept of surface entropy reduction (SER), i.e., the replacement of clusters of flexible, solvent‐exposed residues with residues with lower conformational entropy. This strategy minimizes the loss of conformational entropy upon crystallization and renders crystallization thermodynamically favorable. The method has been successfully used to crystallize more than 15 novel proteins, all stubborn crystallizers. But the choice of suitable sites for mutagenesis is not trivial. Herein, we announce a Web server, the surface entropy reduction prediction server (SERp server), designed to identify mutations that may facilitate crystallization. Suggested mutations are predicted based on an algorithm incorporating a conformational entropy profile, a secondary structure prediction, and sequence conservation. Minor considerations include the nature of flanking residues and gaps between mutation candidates. While designed to be used with default values, the server has many user‐controlled parameters allowing for considerable flexibility. Within, we discuss (1) the methodology of the server, (2) how to interpret the results, and (3) factors that must be considered when selecting mutations. We also attempt to benchmark the server by comparing the servers predictions with successful SER structures. In most cases, the structure yielding mutations were easily identified by the SERp server. The server can be accessed at http://www.doe‐mbi.ucla.edu/Services/SER.


Acta Crystallographica Section D-biological Crystallography | 2007

Protein Crystallization by surface entropy reduction: optimization of the SER strategy

David R. Cooper; Tomasz Boczek; Katarzyna Grelewska; Malgorzata Pinkowska; Malgorzata Sikorska; Michal Zawadzki; Zygmunt S. Derewenda

A strategy of rationally engineering protein surfaces with the aim of obtaining mutants that are distinctly more susceptible to crystallization than the wild-type protein has previously been suggested. The strategy relies on replacing small clusters of two to three surface residues characterized by high conformational entropy with alanines. This surface entropy reduction (or SER) method has proven to be an effective salvage pathway for proteins that are difficult to crystallize. Here, a systematic comparison of the efficacy of using Ala, His, Ser, Thr and Tyr to replace high-entropy residues is reported. A total of 40 mutants were generated and screened using two different procedures. The results reaffirm that alanine is a particularly good choice for a replacement residue and identify tyrosines and threonines as additional candidates that have considerable potential to mediate crystal contacts. The propensity of these mutants to form crystals in alternative screens in which the normal crystallization reservoir solutions were replaced with 1.5 M NaCl was also examined. The results were impressive: more than half of the mutants yielded a larger number of crystals with salt as the reservoir solution. This method greatly increased the variety of conditions that yielded crystals. Taken together, these results suggest a powerful crystallization strategy that combines surface engineering with efficient screening using standard and alternate reservoir solutions.


Structure | 2003

PDZ Tandem of Human Syntenin: Crystal Structure and Functional Properties

Beom Sik Kang; David R. Cooper; Filip Jelen; Yancho Devedjiev; Urszula Derewenda; Zbigniew Dauter; Jacek Otlewski; Zygmunt S. Derewenda

Syntenin, a 33 kDa protein, interacts with several cell membrane receptors and with merlin, the product of the causal gene for neurofibromatosis type II. We report a crystal structure of the functional fragment of human syntenin containing two canonical PDZ domains, as well as binding studies for full-length syntenin, the PDZ tandem, and isolated PDZ domains. We show that the functional properties of syntenin are a result of independent interactions with target peptides, and that each domain is able to bind peptides belonging to two different classes: PDZ1 binds peptides from classes I and III, while PDZ2 interacts with classes I and II. The independent binding of merlin by PDZ1 and syndecan-4 by PDZ2 provides direct evidence for the coupling of syndecan-mediated signaling to actin regulation by merlin.


Structure | 2003

Molecular Roots of Degenerate Specificity in Syntenin'S Pdz2 Domain: Reassessment of the Pdz Recognition Paradigm

Beom Sik Kang; David R. Cooper; Yancho Devedjiev; Urszula Derewenda; Zygmunt S. Derewenda

Crystal structures of the PDZ2 domain of the scaffolding protein syntenin, both unbound and in complexes with peptides derived from C termini of IL5 receptor (alpha chain) and syndecan, reveal the molecular roots of syntenins degenerate specificity. Three distinct binding sites (S(0), S(-1), and S(-2)), with affinities for hydrophobic side chains, function in a combinatorial way: S(-1) and S(-2) act together to bind syndecan, while S(0) and S(-1) are involved in the binding of IL5Ralpha. Neither mode of interaction is consistent with the prior classification scheme, which defined the IL5Ralpha interaction as class I (-S/T-X-phi) and the syndecan interaction as class II (-phi-X-phi). These results, in conjunction with other emerging structural data on PDZ domains, call for a revision of their classification and of the existing model of their mechanism.


Acta Crystallographica Section D-biological Crystallography | 2002

The structure of the FERM domain of merlin, the neurofibromatosis type 2 gene product

Beom Sik Kang; David R. Cooper; Yancho Devedjiev; Urszula Derewenda; Zygmunt S. Derewenda

Neurofibromatosis type 2 is an autosomal dominant disorder characterized by central nervous system tumors. The cause of the disease has been traced to mutations in the gene coding for a protein that is alternately called merlin or schwannomin and is a member of the ERM family (ezrin, radixin and moesin). The ERM proteins link the cytoskeleton to the cell membrane either directly through integral membrane proteins or indirectly through membrane-associated proteins. In this paper, the expression, purification, crystallization and crystal structure of the N-terminal domain of merlin are described. The crystals exhibit the symmetry of space group P2(1)2(1)2(1), with two molecules in the asymmetric unit. The recorded diffraction pattern extends to 1.8A resolution. The structure was solved by the molecular-replacement method and the model was refined to a conventional R value of 19.3% (R(free) = 22.7%). The N-terminal domain of merlin closely resembles those described for the corresponding domains in moesin and radixin and exhibits a cloverleaf architecture with three distinct subdomains. The structure allows a better rationalization of the impact of selected disease-causing mutations on the integrity of the protein.


Expert Opinion on Drug Discovery | 2011

X-ray crystallography: Assessment and validation of protein-small molecule complexes for drug discovery

David R. Cooper; Przemyslaw J. Porebski; Maksymilian Chruszcz; Wladek Minor

Introduction: Crystallography is the key initial component for structure- and fragment-based drug design and can often generate leads that can be developed into high potency drugs. Therefore, huge sums of money are committed based on the outcome of crystallography experiments and their interpretation. Areas covered: This review discusses how to evaluate the correctness of an X-ray structure, focusing on the validation of small molecule–protein complexes. Various types of inaccuracies found within the Protein Data Bank (PDB) are identified and the ramifications of these errors discussed. The reader will gain an understanding of the key parameters that need to be inspected before a structure can be used in drug discovery efforts, as well as an appreciation of the difficulties of correctly interpreting electron density for small molecules. The reader will also be introduced to methods for validating small molecules within the context of a macromolecular structure. Expert opinion: The quality of structures of small molecules in the PDB varies so widely that the databank should not be considered a reliable repository of structural information about these molecules. This is due to the difficulty in identifying and positioning ligands in medium or low resolution macromolecular crystal structures and the immaturity of the available validation tools. The poor quality of small molecule structures in the PDB hinders the derivation of general principles that govern small molecule-protein interactions.


Acta Crystallographica Section D Structural Biology | 2017

CheckMyMetal: a macromolecular metal-binding validation tool

Heping Zheng; David R. Cooper; Przemyslaw J. Porebski; Ivan G. Shabalin; Katarzyna B. Handing; Wladek Minor

The metal-site validation tool CheckMyMetal is described, with examples to follow.


Biochemistry | 2009

Structure and Function of Bacillus subtilis YphP, a Prokaryotic Disulfide Isomerase with a CXC Catalytic Motif

Urszula Derewenda; Tomasz Boczek; Kelly L. Gorres; Minmin Yu; Li-Wei Hung; David R. Cooper; Andrzej Joachimiak; Ronald T. Raines; Zygmunt S. Derewenda

The DUF1094 family contains over 100 bacterial proteins, all containing a conserved CXC motif, with unknown function. We solved the crystal structure of the Bacillus subtilis representative, the product of the yphP gene. The protein shows remarkable structural similarity to thioredoxins, with a canonical αβαβαββα topology, despite low amino acid sequence identity to thioredoxin. The CXC motif is found in the loop immediately downstream of the first β-strand, in a location equivalent to the CXXC motif of thioredoxins, with the first Cys occupying a position equivalent to the first Cys in canonical thioredoxin. The experimentally determined reduction potential of YphP is E°′ = −130 mV, significantly higher than that of thioredoxin and consistent with disulfide isomerase activity. Functional assays confirmed that the protein displays a level of isomerase activity that might be biologically significant. We propose a mechanism by which the members of this family catalyze isomerization using the CXC catalytic site.


Acta Crystallographica Section D-biological Crystallography | 2009

Structure of Thermotoga maritima TM0439: implications for the mechanism of bacterial GntR transcription regulators with Zn2+-binding FCD domains.

Meiying Zheng; David R. Cooper; Nickolas E. Grossoehme; Minmin Yu; Li-Wei Hung; Marcin Cieslik; Urszula Derewenda; Scott A. Lesley; Ian A. Wilson; David P. Giedroc; Zygmunt S. Derewenda

The GntR superfamily of dimeric transcription factors, with more than 6200 members encoded in bacterial genomes, are characterized by N-terminal winged-helix DNA-binding domains and diverse C-terminal regulatory domains which provide a basis for the classification of the constituent families. The largest of these families, FadR, contains nearly 3000 proteins with all-alpha-helical regulatory domains classified into two related Pfam families: FadR_C and FCD. Only two crystal structures of FadR-family members, those of Escherichia coli FadR protein and LldR from Corynebacterium glutamicum, have been described to date in the literature. Here, the crystal structure of TM0439, a GntR regulator with an FCD domain found in the Thermotoga maritima genome, is described. The FCD domain is similar to that of the LldR regulator and contains a buried metal-binding site. Using atomic absorption spectroscopy and Trp fluorescence, it is shown that the recombinant protein contains bound Ni(2+) ions but that it is able to bind Zn(2+) with K(d) < 70 nM. It is concluded that Zn(2+) is the likely physiological metal and that it may perform either structural or regulatory roles or both. Finally, the TM0439 structure is compared with two other FadR-family structures recently deposited by structural genomics consortia. The results call for a revision in the classification of the FadR family of transcription factors.


Proteins | 2006

The DC-module of doublecortin: Dynamics, domain boundaries, and functional implications

Tomasz Cierpicki; Myung Hee Kim; David R. Cooper; Urszula Derewenda; John H. Bushweller; Zygmunt S. Derewenda

The doublecortin‐like (DC) domains, which usually occur in tandem, constitute novel microtubule‐binding modules. They were first identified in doublecortin (DCX), a protein expressed in migrating neurons, and in the doublecortin‐like kinase (DCLK). They are also found in other proteins, including the RP1 gene product which—when mutated—causes a form of inherited blindness. We previously reported an X‐ray structure of the N‐terminal DC domain of DCLK (N‐DCLK), and a solution structure of an analogous module of human doublecortin (N‐DCX). These studies showed that the DC domain has a tertiary fold closely reminiscent of ubiquitin and similar to several GTPase‐binding domains. We now report an X‐ray structure of a mutant of N‐DCX, in which the C‐terminal fragment (residues 139–147) unexpectedly shows an altered, “open” conformation. However, heteronuclear NMR data show that this C‐terminal fragment is only transiently open in solution, and assumes a predominantly “closed” conformation. While the “open” conformation may be artificially stabilized by crystal packing interactions, the observed switching between the “open” and “closed” conformations, which shortens the linker between the two DC‐domains by ∼20 Å, is likely to be of functional importance in the control of tubulin polymerization and microtubule bundling by doublecortin. Proteins 2006.

Collaboration


Dive into the David R. Cooper's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Maksymilian Chruszcz

University of South Carolina

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andrzej Joachimiak

Argonne National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge